Bone Biologics Statistics
Total Valuation
Bone Biologics has a market cap or net worth of $1.14 million. The enterprise value is -$2.89 million.
| Market Cap | 1.14M |
| Enterprise Value | -2.89M |
Important Dates
The last earnings date was Friday, August 14, 2026, after market close.
| Earnings Date | Aug 14, 2026 |
| Ex-Dividend Date | n/a |
Share Statistics
Bone Biologics has 1.80 million shares outstanding. The number of shares has increased by 301.21% in one year.
| Current Share Class | 1.80M |
| Shares Outstanding | 1.80M |
| Shares Change (YoY) | +301.21% |
| Shares Change (QoQ) | +0.08% |
| Owned by Insiders (%) | 0.04% |
| Owned by Institutions (%) | 1.92% |
| Float | 1.79M |
Valuation Ratios
| PE Ratio | n/a |
| Forward PE | n/a |
| PS Ratio | n/a |
| Forward PS | n/a |
| PB Ratio | 0.30 |
| P/TBV Ratio | 0.28 |
| P/FCF Ratio | n/a |
| P/OCF Ratio | n/a |
| PEG Ratio | n/a |
Enterprise Valuation
| EV / Earnings | n/a |
| EV / Sales | n/a |
| EV / EBITDA | n/a |
| EV / EBIT | n/a |
| EV / FCF | n/a |
Financial Position
The company has a current ratio of 8.67
| Current Ratio | 8.67 |
| Quick Ratio | 7.89 |
| Debt / Equity | n/a |
| Debt / EBITDA | n/a |
| Debt / FCF | n/a |
| Interest Coverage | n/a |
Financial Efficiency
Return on equity (ROE) is -54.96% and return on invested capital (ROIC) is -36.38%.
| Return on Equity (ROE) | -54.96% |
| Return on Assets (ROA) | -33.46% |
| Return on Invested Capital (ROIC) | -36.38% |
| Return on Capital Employed (ROCE) | -78.01% |
| Weighted Average Cost of Capital (WACC) | 7.16% |
| Revenue Per Employee | n/a |
| Profits Per Employee | -$1.45M |
| Employee Count | 2 |
| Asset Turnover | n/a |
| Inventory Turnover | n/a |
Taxes
| Income Tax | n/a |
| Effective Tax Rate | n/a |
Stock Price Statistics
The stock price has decreased by -70.00% in the last 52 weeks. The beta is 0.53, so Bone Biologics's price volatility has been lower than the market average.
| Beta (5Y) | 0.53 |
| 52-Week Price Change | -70.00% |
| 50-Day Moving Average | 1.16 |
| 200-Day Moving Average | 1.39 |
| Relative Strength Index (RSI) | 24.88 |
| Average Volume (20 Days) | 815,923 |
Short Selling Information
The latest short interest is 20,981, so 1.17% of the outstanding shares have been sold short.
| Short Interest | 20,981 |
| Short Previous Month | 26,560 |
| Short % of Shares Out | 1.17% |
| Short % of Float | 1.17% |
| Short Ratio (days to cover) | 0.44 |
Income Statement
| Revenue | n/a |
| Gross Profit | n/a |
| Operating Income | -3.06M |
| Pretax Income | -2.89M |
| Net Income | -2.89M |
| EBITDA | n/a |
| EBIT | -3.06M |
| Earnings Per Share (EPS) | -$1.61 |
Balance Sheet
The company has $4.03 million in cash and no debt, with a net cash position of $4.03 million or $2.25 per share.
| Cash & Cash Equivalents | 4.03M |
| Total Debt | n/a |
| Net Cash | 4.03M |
| Net Cash Per Share | $2.25 |
| Equity (Book Value) | 3.92M |
| Book Value Per Share | 2.17 |
| Working Capital | 3.92M |
Cash Flow
| Operating Cash Flow | -2.63M |
| Capital Expenditures | n/a |
| Depreciation & Amortization | n/a |
| Net Borrowing | n/a |
| Free Cash Flow | -2.63M |
| FCF Per Share | -$1.46 |
Margins
| Gross Margin | n/a |
| Operating Margin | n/a |
| Pretax Margin | n/a |
| Profit Margin | n/a |
| EBITDA Margin | n/a |
| EBIT Margin | n/a |
| FCF Margin | n/a |
Dividends & Yields
Bone Biologics does not appear to pay any dividends at this time.
| Dividend Per Share | n/a |
| Dividend Yield | n/a |
| Dividend Growth (YoY) | n/a |
| Years of Dividend Growth | n/a |
| Payout Ratio | n/a |
| Buyback Yield | -301.21% |
| Shareholder Yield | -301.21% |
| Earnings Yield | -263.14% |
| FCF Yield | -239.27% |
Analyst Forecast
| Price Target | n/a |
| Price Target Difference | n/a |
| Analyst Consensus | n/a |
| Analyst Count | n/a |
| Revenue Growth Forecast (3Y) | n/a |
| EPS Growth Forecast (3Y) | n/a |
Fair Value
There are several formulas that can be used to estimate the intrinsic value of a stock.
| Lynch Fair Value | n/a |
| Lynch Upside | n/a |
| Graham Number | n/a |
| Graham Upside | n/a |
Stock Splits
The last stock split was on June 10, 2025. It was a reverse split with a ratio of 1:6.
| Last Split Date | Jun 10, 2025 |
| Split Type | Reverse |
| Split Ratio | 1:6 |
Scores
| Altman Z-Score | n/a |
| Piotroski F-Score | 1 |